Literature DB >> 21976667

Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron.

Jason R Hickok1, Sumit Sahni, Yuliya Mikhed, Marcelo G Bonini, Douglas D Thomas.   

Abstract

N-Myc downstream-regulated gene 1 (NDRG1) is a ubiquitous cellular protein that is up-regulated under a multitude of stress and growth-regulatory conditions. Although the exact cellular functions of this protein have not been elucidated, mutations in this gene or aberrant expression of this protein have been linked to both tumor suppressive and oncogenic phenotypes. Previous reports have demonstrated that NDRG1 is strongly up-regulated by chemical iron chelators and hypoxia, yet its regulation by the free radical nitric oxide ((•)NO) has never been demonstrated. Herein, we examine the chemical biology that confers NDRG1 responsiveness at the mRNA and protein levels to (•)NO. We demonstrate that the interaction of (•)NO with the chelatable iron pool (CIP) and the appearance of dinitrosyliron complexes (DNIC) are key determinants. Using HCC 1806 triple negative breast cancer cells, we find that NDRG1 is up-regulated by physiological (•)NO concentrations in a dose- and time-dependant manner. Tumor cell migration was suppressed by NDRG1 expression and we excluded the involvement of HIF-1α, sGC, N-Myc, and c-Myc as upstream regulatory targets of (•)NO. Augmenting the chelatable iron pool abolished (•)NO-mediated NDRG1 expression and the associated phenotypic effects. These data, in summary, reveal a link between (•)NO, chelatable iron, and regulation of NDRG1 expression and signaling in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976667      PMCID: PMC3308853          DOI: 10.1074/jbc.M111.287052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms.

Authors:  N van Belzen; W N Dinjens; M P Diesveld; N A Groen; A C van der Made; Y Nozawa; R Vlietstra; J Trapman; F T Bosman
Journal:  Lab Invest       Date:  1997-07       Impact factor: 5.662

2.  Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes.

Authors:  K Kokame; H Kato; T Miyata
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

3.  Comparison of features of human breast cancer cell lines and their corresponding tumors.

Authors:  I I Wistuba; C Behrens; S Milchgrub; S Syed; M Ahmadian; A K Virmani; V Kurvari; T H Cunningham; R Ashfaq; J D Minna; A F Gazdar
Journal:  Clin Cancer Res       Date:  1998-12       Impact factor: 12.531

4.  Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer.

Authors:  Zaklina Kovacevic; Sherin Chikhani; David B Lovejoy; Des R Richardson
Journal:  Mol Pharmacol       Date:  2011-06-30       Impact factor: 4.436

5.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.

Authors:  Nghia T V Le; Des R Richardson
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

Review 6.  MYCN in neuronal tumours.

Authors:  Manfred Schwab
Journal:  Cancer Lett       Date:  2004-02-20       Impact factor: 8.679

7.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression.

Authors:  Sucharita Bandyopadhyay; Sudha K Pai; Shigeru Hirota; Sadahiro Hosobe; Yukio Takano; Ken Saito; David Piquemal; Therese Commes; Misako Watabe; Steven C Gross; Ying Wang; Sophia Ran; Kounosuke Watabe
Journal:  Oncogene       Date:  2004-07-22       Impact factor: 9.867

8.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.

Authors:  S K Kurdistani; P Arizti; C L Reimer; M M Sugrue; S A Aaronson; S W Lee
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

9.  Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth.

Authors:  K Doi; T Akaike; H Horie; Y Noguchi; S Fujii; T Beppu; M Ogawa; H Maeda
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

10.  Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers.

Authors:  Hakan Cangul
Journal:  BMC Genet       Date:  2004-09-02       Impact factor: 2.797

View more
  30 in total

1.  Is S-nitrosocysteine a true surrogate for nitric oxide?

Authors:  Jason R Hickok; Divya Vasudevan; Gregory R J Thatcher; Douglas D Thomas
Journal:  Antioxid Redox Signal       Date:  2012-03-12       Impact factor: 8.401

Review 2.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

3.  Effects of nitric oxide on the biological behavior of HepG2 human hepatocellular carcinoma cells.

Authors:  Lei Zhou; Heng Zhang; Jie Wu
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

4.  Mutant p53 expression in fallopian tube epithelium drives cell migration.

Authors:  Suzanne M Quartuccio; Subbulakshmi Karthikeyan; Sharon L Eddie; Daniel D Lantvit; Eoghainín Ó hAinmhire; Dimple A Modi; Jian-Jun Wei; Joanna E Burdette
Journal:  Int J Cancer       Date:  2015-04-11       Impact factor: 7.396

5.  Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins.

Authors:  Yohan Suryo Rahmanto; Danuta S Kalinowski; Darius J R Lane; Hiu Chuen Lok; Vera Richardson; Des R Richardson
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

6.  Nitric oxide reduces oxidative stress in cancer cells by forming dinitrosyliron complexes.

Authors:  Sumit Sahni; Jason R Hickok; Douglas D Thomas
Journal:  Nitric Oxide       Date:  2018-03-06       Impact factor: 4.427

7.  Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases.

Authors:  Jason R Hickok; Divya Vasudevan; William E Antholine; Douglas D Thomas
Journal:  J Biol Chem       Date:  2013-04-01       Impact factor: 5.157

8.  Detection of dinitrosyl iron complexes by ozone-based chemiluminescence.

Authors:  George T Mukosera; Taiming Liu; Abu Shufian Ishtiaq Ahmed; Qian Li; Matilda H-C Sheng; Trent E Tipple; David J Baylink; Gordon G Power; Arlin B Blood
Journal:  Nitric Oxide       Date:  2018-07-27       Impact factor: 4.427

9.  NDRG1 attenuates epithelial-mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signaling.

Authors:  Zhi-Yan Hu; Wei-Bing Xie; Fang Yang; Li-Wei Xiao; Xiao-Yan Wang; Shi-You Chen; Zu-Guo Li
Journal:  Biochim Biophys Acta       Date:  2015-06-10

10.  NDRG1 deficiency attenuates fetal growth and the intrauterine response to hypoxic injury.

Authors:  Jacob Larkin; Baosheng Chen; Xiao-Hua Shi; Takuya Mishima; Koichi Kokame; Yaacov Barak; Yoel Sadovsky
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.